Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis.
Edwards SM; Evans DG; Hope Q; Norman AR; Barbachano Y; Bullock S; Kote-Jarai Z; Meitz J; Falconer A; Osin P; Fisher C; Guy M; Jhavar SG; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Forrest MS; Dearnaley DP; Ardern-Jones AT; Page EC; Easton DF; Eeles RA; British Journal Of Cancer, 2010, vol. 103, issue 6, p 918, ISSN 15321827. ISBN 15321827.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef